https://www.selleckchem.com/pr....oducts/liraglutide.h
In agreement with this, a strong positive correlation of mRNA expression between DZIP3 and Cyclin D1 in different cancer types was observed. Additionally, DZIP3 regulated several cell cycle proteins by modulating the Cyclin D1-E2F axes. Taken together, this study demonstrates for the first time that DZIP3 uses a unique two-pronged mechanism in its stabilization of Cyclin D1 to drive cell-cycle and cancer progression. SIGNIFICANCE These findings show that DZIP3 is a novel driver of cell-cycle and cancer progression via its control of
Like
Comment
Share
